| Rasburicase - Wikipedia, the free encyclopedia Rasburicase (brand names: Elitek in the US, and Fasturtec in Europe) is a recombinant version of urate oxidase, an enzyme which occurs in many mammals but not in humans. Read More |
| rasburicase medical facts from Drugs.com Physician reviewed rasburicase patient information - includes rasburicase description, dosage and directions. Read More |
| ELITEKĀ® (rasburicase) Powder for solution, for intravenous ... HIGHLIGHTS OF PRESCRIBING INFORMATION: These highlights do not include all the information needed to use ELITEK safely and effectively. See full prescribing ... Read More |
| Elitek (Rasburicase) Drug Information: Description, User Reviews ... Learn about the prescription medication Elitek (Rasburicase), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Rasburicase (Elitek): a novel agent for tumor lysis syndrome 1 From the Department of Pharmacy Services, Baylor University Medical Center, Dallas, Texas. Read More |
| Rasburicase - National Cancer Institute - Comprehensive Cancer ... This page contains brief information about rasburicase and a collection of links to more information about the use of this drug, research results, and ongoing ... Read More |
| Rasburicase Facts and Comparisons at Drugs.com All about Rasburicase. View complete and up to date Rasburicase information - part of the Drugs.com trusted medication database. Read More |
| Rasburicase (Intravenous Route) - MayoClinic.com Rasburicase injection treats high uric acid blood levels (hyperuricemia) that are caused by cancer treatment. This medicine is used in adults and children with ... Read More |
| rasburicase - MSN Health - Medications Rasburicase helps keep uric acid levels in the body from getting too high. Uric acid levels can increase during cancer treatments when tumor cells bre Read More |
| rasburicase - definition of rasburicase in the Medical dictionary ... rasburicase, an antineoplastic antimetabolite used to reduce uric acid levels in children with leukemia or lymphoma and in chemotherapy patients with solid tumor ... Read More |